Key result
Drug-coated balloon-based percutaneous coronary intervention was associated with a lower rate of all-cause mortality compared with drug-eluting stent-only intervention in patients with coronary artery disease and chronic heart failure.
Why the study?
Heart failure in CAD patients is associated with poor prognosis, but the clinical significance of DCB-based PCI in CAD patients with HF is unknown.
Does drug-coated balloon-based PCI reduce all-cause mortality in coronary artery disease patients with chronic heart failure compared to DES-only PCI?
Cohort (n=328)
No
Does drug-coated balloon-based PCI reduce all-cause mortality in coronary artery disease patients with chronic heart failure compared to DES-only PCI?
Answers are grounded in this paper and cite their sources.
In CAD patients with chronic heart failure, a DCB-based PCI strategy was associated with significantly lower all-cause mortality and reduced stent burden compared to a DES-only strategy.
Background: Drug-coated balloon (DCB) is a novel treatment option for percutaneous coronary intervention (PCI). The presence of heart failure (HF) in patients with coronary artery disease (CAD) is associated with a poor prognosis. However, the clinical significance of DCB-based PCI in CAD patients with HF is unknown. Methods and Results: This was a retrospective analysis of a cohort study from a prospective, single center registry from 2015 to 2024. We enrolled 258 CAD patients with chronic HF who underwent PCI with DCB or in combination with a drug-eluting stent (DES). Propensity score matching analysis was performed between the DCB-based PCI and DES-only PCI groups. The primary endpoint of this study was all-cause mortality. Baseline clinical characteristics were comparable between the groups. The total DES number and length were significantly reduced in patients with DCB-based PCI than in those with DES-only PCI. Kaplan-Meier analysis revealed that the DCB-based PCI group had a significantly lower rate of all-cause mortality compared with the DES-only group (log-rank test, P=0.04). Conclusions: In CAD patients with chronic HF, DCB-based PCI was associated with a lower risk of mortality compared with DES-only PCI.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2026) conducted a cohort in Coronary artery disease with chronic heart failure (n=328). Drug-coated balloon (DCB)-based percutaneous coronary intervention vs. Drug-eluting stent (DES)-only percutaneous coronary intervention was evaluated on All-cause mortality (p=0.04). Drug-coated balloon-based percutaneous coronary intervention was associated with a lower rate of all-cause mortality compared with drug-eluting stent-only intervention in patients with coronary artery disease and chronic heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: